The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Open accessAbstract
Chronic viral infections often result in T cell exhaustion. To determine the molecular signature of exhaustion, we compared the gene-expression profiles of dysfunctional lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells from chronic infection to functional LCMV-specific effector and memory CD8(+) T cells generated after acute infection. These data showed that exhausted CD8(+) T cells: (1) overexpressed several inhibitory receptors, including PD-1, (2) had major changes in T cell receptor and cytokine signaling pathways, (3) displayed altered expression of genes involved in chemotaxis, adhesion, and migration, (4) expressed a distinct set of transcription factors, and (5) had profound metabolic and bioenergetic deficiencies. T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes. Thus, functional exhaustion is probably due to both active suppression and passive defects in signaling and metabolism. These results provide a framework for designing rational immunotherapies during chronic infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T cells acquiring multiple inhibitory surface molecules in persistent disease settings such as chronic infection [37,38] and malignancies [30,**39,40], which effectively prevent T cell activation.”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [37]
In the citing paper
“Secretion of TNF-α in some populations of cells is reduced because of the contemporary arrest of p38-MAPK and PD-1 pathways.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“However, the telomerase activity in CD8+/CD45RA+ T cells is improved by blocking only the p38 pathway but not the PD-1 signaling, indicating that non-overlapping signaling pathways are involved (193, 194).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“In these cells that present characteristics of immune senescence (decreased proliferation, lower telomerase activity, and increased presence of DNA damage), the simultaneous blockade of both p38-MAPK and PD-1 signaling supports their proliferation, both in young and in older human beings.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationGreenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Self-citationWherry, E. J., Blattman, J. N., Murali‐Krishna, K., der Most, R. G. V., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,645
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,007
CD 8+ T‐cell effector function and transcriptional regulation during HIV pathogenesis
Demers, K., Reuter, M. A., & Betts, M. R. (2013) · Immunological Reviews · doi:10.1111/imr.12069 · Cited by 78
Molecular and genetic inflammation networks in major human diseases
Zhao, Y., Forst, C. V., Sayegh, C. E., Wang, I., Yang, X., & Zhang, B. (2016) · Molecular BioSystems · doi:10.1039/c6mb00240d · Cited by 72
Rådestad, E., Klynning, C., Stikvoort, A., Mogensen, O. E., Nava, S., Magalhaes, I., & Uhlin, M. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1535730 · Cited by 71
Kahan, S. M., Bakshi, R. K., Ingram, J. T., Hendrickson, R. C., Lefkowitz, E. J., Crossman, D. K., Harrington, L. E., Weaver, C. T., & Zajac, A. J. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl6322 · Cited by 67
Gestermann, N., Saugy, D., Martignier, C., Tillé, L., Fuertes Marraco, S. A., Zettl, M., Tirapu, I., Speiser, D. E., & Verdeil, G. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1736792 · Cited by 69
Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice
Kalia, V., Yuzefpolskiy, Y., Vegaraju, A., Xiao, H., Baumann, F. M., Jatav, S., Church, C. D., Prlic, M., Jha, A., Nghiem, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba6006 · Cited by 71
Self-citationImmune checkpoint receptors in autoimmunity
Burke, K. P., Patterson, D. G., Liang, D., & Sharpe, A. H. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102283 · Cited by 70
Barbarin, A., Cayssials, É., Jacomet, F., Núñez, N. G., Basbous, S., Lefèvre, L., Abdallah, M., Piccirilli, N., Morin, B., Lavoué, V., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00316 · Cited by 69
Almutairi, S. M., Ali, A. K., He, W. R., Yang, D.-S., Ghorbani, P., Wang, L., Fullerton, M. D., & Lee, S.-H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005892 · Cited by 74
Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy
Zebley, C. C., Gottschalk, S. M., & Youngblood, B. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.008 · Cited by 71
Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells.
Youngblood, B., Wherry, E. J., & Ahmed, R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834ddcf2 · Cited by 68
Self-citationLeem, G., Park, J., Jeon, M., Kim, E.-S., Kim, S. W., Lee, Y. J., Choi, S. J., Choi, B., Park, S., Jung, I., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001650 · Cited by 68
Chen, J., Song, Y., Miao, F., Chen, G., Zhu, Y., Wu, N., Pang, L., Chen, Z., & Chen, X. (2021) · Cancer Science · doi:10.1111/cas.15033 · Cited by 70
Prakadan, S. M., Alvarez-Breckenridge, C. A., Markson, S. C., Kim, A. E., Klein, R. H., Nayyar, N., Navia, A. W., Kuter, B. M., Kolb, K. E., Bihun, I. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25860-5 · Cited by 66
Adenoviral-based vaccine promotes neoantigen-specific CD8 + T cell stemness and tumor rejection
D’Alise, A. M., Brasu, N., Intinis, C. D., Leoni, G., Russo, V., Langone, F., Baev, D. V., Micarelli, E., Petiti, L., Picelli, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7604 · Cited by 69
He, S., Kato, K., Jiang, J. K., Wahl, D. R., Mineishi, S., Fisher, E. M., Murasko, D. M., Glick, G. D., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020107 · Cited by 71
The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection
Moffett, H., Cartwright, A. N., Kim, H.-J., Godec, J., Pyrdol, J. W., Äijö, T., Martinez, G., Rao, A., Lu, J., Golub, T., et al. (2017) · Nature Immunology · doi:10.1038/ni.3755 · Cited by 74
Lewis, K. E., Selby, M., Masters, G. R., Valle, J., Dito, G., Curtis, W., García, R., Mink, K. A., Waggie, K. S., Holdren, M. S., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1377873 · Cited by 68
Dynamic Post-Transcriptional Events Governing CD8+ T Cell Homeostasis and Effector Function
Salerno, F., Turner, M., & Wolkers, M. C. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.001 · Cited by 59
T Cell Exhaustion and CAR‐T Immunotherapy in Hematological Malignancies
Tang, L., Zhang, Y., Hu, Y., & Mei, H. (2021) · BioMed Research International · doi:10.1155/2021/6616391 · Cited by 72
Shao, M., Teng, X., Guo, X., Zhang, H., Huang, Y., Cui, J., Si, X., Ding, L., Wang, X., Li, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202103508 · Cited by 67
Haymaker, C., Wu, R. C. H., Ritthipichai, K., Bernatchez, C., Forget, M., Chen, J. Q., Liu, H., Wang, E., Marincola, F. M., Hwu, P., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1014246 · Cited by 66
Ishigaki, K., Shoda, H., Kochi, Y., Yasui, T., Kadono, Y., Tanaka, S., Fujio, K., & Yamamoto, K. (2015) · Scientific Reports · doi:10.1038/srep12937 · Cited by 68
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
Barili, V., Fisicaro, P., Montanini, B., Acerbi, G., Filippi, A., Forleo, G., Romualdi, C., Ferracin, M., Guerrieri, F., Pedrazzi, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14137-7 · Cited by 70
Deng, S., Sun, Z., Qiao, J., Liang, Y., Liu, L., Dong, C., Shen, A., Wang, Y., Tang, H., Fu, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132000 · Cited by 67
Cook, K. D., Kline, H. C., & Whitmire, J. K. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4hi1214-594r · Cited by 66
Cerisuelo, M. C., Laurie, S. J., Mathews, D. V., Winterberg, P. D., Larsen, C. P., Adams, A. B., & Ford, M. L. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14350 · Cited by 66
A transgenic mouse model for HLA-B*57:01–linked abacavir drug tolerance and reactivity
Cardone, M., Garcia, K., Tilahun, M. E., Boyd, L. F., Gebreyohannes, S., Yano, M., Roderiquez, G., Akue, A. D., Juengst, L., Mattson, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99321 · Cited by 68
Epigenetic Regulation of T Cell Memory: Recalling Therapeutic Implications
Tough, D. F., Rioja, I., Modis, L. K., & Prinjha, R. K. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.008 · Cited by 67
Topchyan, P., Lin, S., & Cui, W. (2023) · Immune Network · doi:10.4110/in.2023.23.e41 · Cited by 73
Ahn, T., Bae, E., & Seo, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.004 · Cited by 71
Lu, B., Chen, L., Liu, L., Zhu, Y., Wu, C., Jiang, J., & Zhang, X. (2011) · Immunologic Research · doi:10.1007/s12026-011-8227-9 · Cited by 67
Furlan, S. N., Watkins, B. K., Tkachev, V., Flynn, R. P., Cooley, S., Ramakrishnan, S., Singh, K., Giver, C., Hamby, K., Stempora, L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3231 · Cited by 64
Plumlee, C. R., Obar, J. J., Colpitts, S. L., Jellison, E. R., Haining, W. N., Lefrançois, L., & Khanna, K. M. (2015) · Scientific Reports · doi:10.1038/srep12264 · Cited by 66
Self-citationT Cell Cosignaling Molecules in Transplantation
Ford, M. L. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.012 · Cited by 67
Shaabani, N., Duhan, V., Khairnar, V., Gassa, A., Ferrer-Tur, R., Häussinger, D., Recher, M., Zelinskyy, G., Liu, J., Dittmer, U., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.350 · Cited by 64
Yin, N., Li, X., Zhang, X., Xue, S., Cao, Y., Niedermann, G., Lu, Y., & Xue, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01826-z · Cited by 74
Shankar, E. M., Che, K. F., Messmer, D., Lifson, J. D., & Larsson, M. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00175 · Cited by 66
Wilson, E. B., Kidani, Y., Elsaesser, H. J., Barnard, J., Raff, L., Karp, C. L., Bensinger, S. J., & Brooks, D. G. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.009 · Cited by 64
Liu, D., Krummey, S. M., Badell, I. R., Wagener, M. E., Schneeweis, L. A., Stetsko, D. K., Suchard, S. J., Nadler, S. G., & Ford, M. L. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130902 · Cited by 64
Probing CD8 T Cell Responses with Listeria monocytogenes Infection
Condotta, S. A., Richer, M. J., Badovinac, V. P., & Harty, J. T. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394590-7.00005-1 · Cited by 64
Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling
Marro, B. S., Ware, B. C., Žák, J., de la Torre, J. C., Rosen, H., & Oldstone, M. B. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700878114 · Cited by 64
Wang, S., Sun, F., Li, M., Qian, J., Chen, C., Wang, M., Zang, X., Li, D., Yu, M., & Du, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1642-x · Cited by 64
Behar, S. M., Carpenter, S. M., Booty, M. G., Barber, D. L., & Jayaraman, P. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.003 · Cited by 65
Self-citationImmune Responses to Retroviruses
Sáez‐Cirión, A., & Manel, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052155 · Cited by 66
Targeting the NFAT:AP-1 transcriptional complex on DNA with a small-molecule inhibitor
Mognol, G. P., González‐Avalos, E., Ghosh, S., Spreafico, R., Gudlur, A., Rao, A., Damoiseaux, R. D., & Hogan, P. G. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820604116 · Cited by 62
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease
Kemeny, H. R., Elsamadicy, A. A., Farber, S. H., Champion, C. D., Lorrey, S., Chongsathidkiet, P., Woroniecka, K. I., Cui, X., Shen, S. H., Rhodin, K. E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3486 · Cited by 63
Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML
Nixdorf, D., Sponheimer, M., Berghammer, D., Engert, F., Bader, U., Philipp, N., Pasikhani, M. K., Straub, T., Rohrbacher, L., Wange, L. E., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01905-0 · Cited by 63
Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1
Mortezaee, K., & Majidpoor, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114824 · Cited by 63
Mays, L. E., Wang, L., Lin, J., Bell, P. L., Crawford, A., Wherry, E. J., & Wilson, J. M. (2013) · Molecular Therapy · doi:10.1038/mt.2013.134 · Cited by 69
Self-citationYoon, S. K., Seo, Y. B., Im, S. J., Bae, S. H., Song, D. S., You, C. R., Jang, J., Yang, S. H., Suh, Y. S., Song, J. S., et al. (2014) · Liver International · doi:10.1111/liv.12530 · Cited by 62
Zhou, Q., Xiao, H., Liu, Y., Peng, Y., Yuan, H., Yagita∥, H., Chandler, P., Munn, D. H., Mellor, A. L., Fu, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001821 · Cited by 62
TIMs: central regulators of immune responses
Hafler, D. A., & Kuchroo, V. K. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20082429 · Cited by 62
MHC–peptide tetramers for the analysis of antigen-specific T cells
Sims, S., Willberg, C. B., & Klenerman, P. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.66 · Cited by 62
Landrith, T. A., Sureshchandra, S., Rivera, A., Jang, J. C., Rais, M., Nair, M. G., Messaoudi, I., & Wilson, E. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00335 · Cited by 64
Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma
Schadendorf, D., Nghiem, P., Bhatia, S., Hauschild, A., Saïag, P., Mahnke, L. A., Hariharan, S., & Kaufman, H. L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1338237 · Cited by 66
Exhausted and Senescent T Cells at the Maternal-Fetal Interface in Preterm and Term Labor
Slutsky, R., Romero, R. J., Xu, Y., Galaz, J., Miller, D., Done, B., Tarca, A. L., Gregor, S., Hassan, S. S., Leng, Y., et al. (2019) · Journal of Immunology Research · doi:10.1155/2019/3128010 · Cited by 62
Lee, Y. J., Kim, J. Y., Jeon, S. H., Nam, H., Jung, J. H., Jeon, M., Kim, E.-S., Bae, S. J., Ahn, J., Yoo, T.-K., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abn8390 · Cited by 56
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Alahdal, M., & Elkord, E. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109177 · Cited by 60
Minnie, S. A., Waltner, O. G., Zhang, P., Takahashi, S., Nemychenkov, N. S., Ensbey, K. S., Schmidt, C. R., Legg, S. R. W., Comstock, M., Boiko, J. R., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adg1094 · Cited by 58
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model
Zehn, D., & Wherry, E. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-15774-0_10 · Cited by 60
Self-citationMechanism of T cell exhaustion in a chronic environment
Jin, H.-T., Jeong, Y. H., Park, H.-J., & Ha, S. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.4.217 · Cited by 62
Self-citationDurward, M., Radhakrishnan, G., Harms, J. S., Bareiss, C., Magnani, D. M., & Splitter, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034925 · Cited by 60
Epstein–Barr virus and multiple sclerosis. From evidence to therapeutic strategies
Menéndez, S. F., Fernández-Morán, M., Fernández‐Vega, I., Pérez-Álvarez, Á. I., & Villafani, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.013 · Cited by 68
Miao, J., Xu, L., Hu, Y., Piao, C., Wu, X., Liu, X., Huang, C., Wang, Y., Li, D., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21155 · Cited by 66
CD4 + T help promotes influenza virus-specific CD8 + T cell memory by limiting metabolic dysfunction
Cullen, J. G., McQuilten, H. A., Quinn, K. M., Olshansky, M., Russ, B. E., Morey, A., Wei, S., Prier, J. E., Gruta, N. L. L., Doherty, P. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808849116 · Cited by 65
Liu, X., Li, F., Niu, H., Ma, L., Chen, J., Zhang, Y., Peng, L., Gan, C., Ma, X., & Zhu, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02350 · Cited by 61
Li, C., Li, W., Xiao, J., Jiao, S., Teng, F., Xue, S., Zhang, C., Sheng, C., Leng, Q., Rudd, C. E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404578 · Cited by 60
Layilin augments integrin activation to promote antitumor immunity
Mahuron, K. M., Moreau, J. M., Glasgow, J. E., Boda, D. P., Pauli, M. L., Gouirand, V., Panjabi, L., Grewal, R., Luber, J. M., Mathur, A. N., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192080 · Cited by 60
Progress of immune checkpoint LAG‑3 in immunotherapy (Review)
Shan, C., Li, X., & Zhang, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.12070 · Cited by 60
EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia
Cid, L. L., Roessner, P. M., Chapaprieta, V., Öztürk, S., Roider, T., Bordas, M., Ízcue, A., Colomer, D., Dietrich, S., Stilgenbauer, S., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01198-1 · Cited by 64
Emerging Roles for the FCRL Family Members in Lymphocyte Biology and Disease
Li, F. J., Won, W.-J., Becker, E., Easlick, J. L., Tabengwa, E. M., Li, R., Shakhmatov, M. A., Honjo, K., Burrows, P. D., & Davis, R. S. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_2 · Cited by 60
Dougan, S. K., Dougan, M. L., Kim, J., Turner, J., Ogata, S., Cho, H.-I., Jaenisch, R., Celis, E., & Ploegh, H. L. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0047 · Cited by 60
Caserta, S., Kleczkowska, J., Mondino, A., & Zamoyska, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001867 · Cited by 64
Istaces, N., Splittgerber, M., Silva, V. L., Nguyen, M., Thomas, S., Le, A., Achouri, Y., Calonne, E., Defrance, M., Fuks, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11233-6 · Cited by 65
Sandu, I., Cerletti, D., Claassen, M., & Oxenius, A. (2020) · Nature Communications · doi:10.1038/s41467-020-18256-4 · Cited by 60
Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance
Wagle, M. V., Vervoort, S. J., Kelly, M. J., Byl, W. V. D., Peters, T. J., Martin, B. P., Martelotto, L. G., Nüssing, S., Ramsbottom, K. M., Torpy, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23044-9 · Cited by 62
Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
Ta, T. M., Malik, S., Anderson, E. M., Jones, A. D., Perchik, J., Freylikh, M., Sardo, L., Klase, Z. A., & Izumi, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.862270 · Cited by 61
Jaiswal, A., Verma, A., Dannenfelser, R., Melssen, M. M., Tirosh, I., Izar, B., Kim, T., Nirschl, C. J., Devi, K. S. P., Olson, W. C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.005 · Cited by 61
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Chi, X., Luo, S., Ye, P., Hwang, W., Cha, J., Yan, X., & Yang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104771 · Cited by 62
Zhou, Z., Wang, J., Wang, J., Yang, S., Wang, R., Zhang, G., Li, Z., Shi, R., Wang, Z., & Lu, Q. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02047-2 · Cited by 66
Rodrigue‐Gervais, I. G., Rigsby, H., Jouan, L., Sauvé, D., Sékaly, R., Willems, B. E., & Lamarre, D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902522 · Cited by 58
Complement Regulates CD4 T-Cell Help to CD8 T Cells Required for Murine Allograft Rejection
Vieyra, M. B., Leisman, S. A., Raedler, H., Kwan, W.-H., Yang, M., Strainic, M. G., Medof, M. E., & Heeger, P. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.038 · Cited by 59
Guo, X.-Z. J., Dash, P., Calverley, M., Tomchuck, S. L., Dallas, M. H., & Thomas, P. G. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.54 · Cited by 59
Nice, T. J., Osborne, L. C., Tomov, V. T., Artis, D., Wherry, E. J., & Virgin, H. W. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005684 · Cited by 61
Self-citationTassi, E., Grazia, G., Vegetti, C., Bersani, I., Bertolini, G., Molla, A., Baldassari, P., Andriani, F., Roz, L., Sozzi, G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1387 · Cited by 57
Molecular Dissection of CD8 + T-Cell Dysfunction
Wang, C., Singer, M., & Anderson, A. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.008 · Cited by 60
A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice
Gefen, T., Castro, I., Muharemagic, D., Puplampu-Dove, Y., Patel, S., & Gilboa, E. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.06.023 · Cited by 61
Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance
Yu, H., Tian, Y., Wang, Y., Mineishi, S., & Zhang, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00093 · Cited by 59
Gasparetto, M., Payne, F., Nayak, K., Kraiczy, J., Glemas, C., Philip-McKenzie, Y., Ross, A., Edgar, R. D., Zerbino, D. R., Salvestrini, C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.017 · Cited by 60
Xu, H., Wang, X., Malam, N., Aye, P. P., Alvarez, X. A., Lackner, A. A., & Veazey, R. S. (2015) · Journal of Virology · doi:10.1128/jvi.02471-15 · Cited by 58
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
Bachireddy, P., Azizi, E., Burdziak, C., Nguyen, V. N., Ennis, C. S., Maurer, K., Park, C. Y., Choo, Z.-N., Li, S., Gohil, S. H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109992 · Cited by 55
Emerging CAR T Cell Strategies for the Treatment of AML
Vishwasrao, P., Li, G., Boucher, J. C., Smith, D. L., & Hui, S. K. (2022) · Cancers · doi:10.3390/cancers14051241 · Cited by 61
Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells
Meng, X., Layhadi, J. A., Keane, S. T., Cartwright, N., Durham, S. R., & Shamji, M. H. (2023) · Asia Pacific Allergy · doi:10.5415/apallergy.0000000000000128 · Cited by 70
PD-L1 Limits the Mucosal CD8+ T Cell Response to Chlamydia trachomatis
Fankhauser, S. C., & Starnbach, M. N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301657 · Cited by 56
Programmed Death-1 Shapes Memory Phenotype CD8 T Cell Subsets in a Cell-Intrinsic Manner
Charlton, J., Chatzidakis, I., Tsoukatou, D., Boumpas, D., Garinis, G. A., & Mamalaki, C. (2013) · Journal of Immunology · doi:10.4049/jimmunol.1201617 · Cited by 63
Pathogen-Driven Cancers and Emerging Immune Therapeutic Strategies
Vandeven, N. A., & Nghiem, P. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0179 · Cited by 58
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
Waugh, K. A., Leach, S. M., Moore, B. L., Bruno, T. C., Buhrman, J. D., & Slansky, J. E. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600589 · Cited by 59
CAR T cells and checkpoint inhibition for the treatment of glioblastoma
Shen, S. H., Woroniecka, K. I., Barbour, A. B., Fecci, P. E., Sanchez-Perez, L. A., & Sampson, J. H. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1727436 · Cited by 62
McPherson, R. C., Konkel, J. E., Prendergast, C. T., Thomson, J. P., Ottaviano, R., Leech, M. D., Kay, O., Zandee, S., Sweenie, C. H., Wraith, D. C., et al. (2014) · eLife · doi:10.7554/elife.03416 · Cited by 61
Metadata
- Authors
- Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R.
- Affiliations
- Emory University (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Wherry, E. John
- Ahmed, Rafi
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 27
- Issue
- 4
- Pages
- 670-684
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2040353461
- Cited by
- 2,103
- References
- 56
- Citations by year
- 2026: 110 · 2025: 148 · 2024: 140 · 2023: 144 · 2022: 139 · 2021: 180 · 2020: 161 · 2019: 138 · 2018: 119 · 2017: 102 · 2016: 112 · 2015: 116 · 2014: 88 · 2013: 83 · 2012: 80
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-11-26)
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2116 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI071309, AI 30048, R01AI071309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- CD8+ T cell exhaustion, chronic viral infection, lymphocytic choriomeningitis virus, PD-1, inhibitory receptors, T cell receptor signaling, cytokine signaling, T cell metabolism, bioenergetics, T cell migration, transcription factors, T cell anergy, gene expression profiling, immunotherapy
- MeSH terms
- Animals, Cell Differentiation, Chronic Disease, Female, Flow Cytometry, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Molecular Sequence Data, Phenotype, Virus Diseases, Gene Expression, Clonal Anergy, CD8-Positive T-Lymphocytes, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review